Back to search

Japan· JP-6119401D2058

テイコプラニン

A teicoplanin product containing テイコプラニン, registered in Japan by Meiji Seika ファルマ, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

On Japan’s NHI price listATC J01XA02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedテイコプラニンATCJ01XA02REGISTER NO.JP-6119401D2058PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Teicoplanin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01XA02 (teicoplanin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 8 of them publish a price we can compare per daily dose

Teicoplanin · ATC J01XA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
テイコプラニン
Manufacturer
Meiji Seika ファルマ
Country
Japan (JP)
ATC code
J01XA02
ATC class
Teicoplanin
Defined daily dose
0.4 g, P
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b7869871-c36e-49b7-a5dc-03bfabbd4402
GET /v1/drugs/b7869871-c36e-49b7-a5dc-03bfabbd4402?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "400mg1瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6119401D2058",
  "category": "注射薬",
  "price_yen": 2492,
  "generic_name": "テイコプラニン",
  "product_name_jp": null,
  "therapeutic_class": "6119",
  "transitional_expiry": null
}

See everything about teicoplanin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.